![]() |
|
|
Vol. 297, Issue 1, 395-402, April 2001
Departments of Psychiatry and Behavioral Neurosciences and Pharmacology, and the Cellular and Clinical Neurobiology Training Program, Wayne State University School of Medicine, Detroit, Michigan
| |
Abstract |
|---|
|
|
|---|
Little is currently known regarding the electrophysiological response elicited by 5-hydroxytryptamine-7 (5-HT7) receptor stimulation in the brain. Previous anatomical studies have shown that the anterior thalamus expresses a high density of 5-HT7 receptors. Therefore, we used whole-cell recording techniques in the in vitro brain slices to examine the effects of serotonin on neurons of the anterodorsal nucleus of the thalamus (ADn). Bath application of 5-HT induces a large membrane depolarization and inward current in neurons of the ADn. Since these cells expressed 5-HT7 receptor mRNA, as determined by single-cell reverse transcriptase-polymerase chain reaction, we pharmacologically characterized the 5-HT receptor mediating this response. We found that the 5-HT1 and 5-HT7 agonists 5-carboxamidotryptamine (5-CT) and 5-methoxytryptamine mimicked the response to 5-HT, whereas the 5-HT2 agonist 2,5-dimethoxy-4-iodoamphetamine did not. Consistent with the involvement of a 5-HT7 receptor, 5-CT was approximately 18 times more potent than 5-HT. Furthermore, administration of the 5-HT1A and 5-HT7 agonist 8-hydroxydipropylaminotetralin mimicked and antagonized the effect of serotonin, suggesting it acted as a partial agonist. To determine if either the 5-HT1 or 5-HT7 receptor mediated the 5-HT-induced inward current, we used antagonists. We found that the 5-HT7 ligands ritanserin, methylsergide, LSD, and mesulergine could inhibit the 5-HT-induced inward current, whereas the 5-HT1 antagonist cyanopindolol had no effect. The pA2 value determined for mesulergine closely approximated that expected for a 5-HT7 receptor. Finally, we found that bath application of the selective antagonist SB-269770 blocks the 5-HT-induced inward current. These results identify the receptor mediating the serotonin-induced membrane depolarization in the ADn as the 5-HT7 subtype.
| |
Introduction |
|---|
|
|
|---|
The
effects of serotonin (5-hydroxytryptamine, 5-HT) in the central nervous
system are mediated by multiple serotonin receptors. There are
currently 14 receptor subtypes known, classified into seven receptor
subfamilies based on their sequence homology, pharmacology, and signal
transduction cascade (Hoyer et al., 1994
). During the last two decades,
there has been a growing understanding of the electrophysiological
response mediated by many of these different receptor subtypes
(Andrade, 1998
; Barnes and Sharp, 1999
). However, this understanding is
still incomplete. There are receptor subtypes that have no identified
electrophysiological function, and there are also well characterized
physiological responses to 5-HT to which no known receptor can be
assigned. Outstanding among the first of these is the
5-HT7 receptor subtype, a subtype that is well
characterized from a pharmacological standpoint, but poorly characterized in terms of in situ electrophysiology in the brain.
The 5-HT7 receptor was originally cloned from
several mammalian species, including rat (Lovenberg et al., 1993
;
Meyerhof et al., 1993
; Ruat et al., 1993
; Shen et al., 1993
), mouse
(Plassat et al., 1993
), guinea pig (Tsou et al., 1994
), and human (Bard et al., 1993
), based on its homology to other serotonin receptors. As
determined from sequence analysis, this serotonin receptor is part of
the G-protein superfamily of receptors containing the typical seven
transmembrane regions (Lovenberg et al., 1993
; Meyerhof et al., 1993
;
Plassat et al., 1993
; Shen et al., 1993
; Tsou et al., 1994
; Stam et
al., 1997
). In heterologous expression systems, the
5-HT7 receptor increases cAMP accumulation when
stimulated by 5-HT (Meyerhof et al., 1993
; Plassat et al., 1993
; Shen
et al., 1993
; Tsou et al., 1994
; Stam et al., 1997
) and hence is thought to couple to G
s.
The 5-HT7 receptor pharmacology has been
extensively studied in heterologous expression systems. In such
systems, the 5-HT7 receptor can be stimulated
with 5-HT as well as 5-HT1 agonists. For example,
the rank order of potency at this receptor for several commonly used
serotonin agonists is 5-carboxamidotryptamine (5-CT) > 5-HT
5-methoxytryptamine (5-MeOT) > 8-hydroxydipropylaminotetralin (8-OHDPAT)
2,5-dimethoxy-4-iodoamphetamine (DOI) (Lovenberg et al.,
1993
; Plassat et al., 1993
; Ruat et al., 1993
; Hoyer et al., 1994
;
Adham et al., 1998
). Conversely, many compounds traditionally considered 5-HT2 antagonists, such as ritanserin,
methysergide, or mesulergine, are effective 5-HT7
antagonists (Bard et al., 1993
; Lovenberg et al., 1993
; Shen et al.,
1993
). Thus, the 5-HT7 receptor can be
characterized broadly as a receptor activated by
"5-HT1 " agonists, but inhibited by
"5-HT2 " antagonists. This distinct
pharmacological profile suggests a viable strategy for identifying
5-HT7 receptor-mediated responses in the central
nervous system. Additionally, the recently available antagonist
SB-269770 can be used to further characterize a
5-HT7-mediated response (Lovell et al., 1999;
Bacon and Beck, 2000
).
The distribution of 5-HT7 receptors in the
central nervous system has been determined using in situ hybridization
and receptor autoradiography using tritiated 5-CT. In both the guinea
pig and the rat, there is a comparable distribution between the
5-HT7 mRNA determined by these assays (To et al.,
1995
; Gustafson et al., 1996
; Heidmann et al., 1998
).
5-HT7 receptors are widely expressed in the
brain, with their highest expression levels being found in the
anterior, paraventricular, and rhomboid nuclei of the thalamus and the
CA3 region of the hippocampus (Gustafson et al., 1995
; To et al.,
1995
).
In summary, the 5-HT7 receptor is positively linked to adenylate cyclase, is abundantly expressed in limbic regions, and displays a distinct pharmacological profile. Yet, despite these defining characteristics, its functional role in the brain remains poorly understood. Therefore, we used whole-cell patch clamp recording to examine the effect of 5-HT in the anterior thalamus, a region where 5-HT7 receptors are abundantly expressed. In the anterodorsal nucleus of the thalamus (ADn), we found that 5-HT induces a membrane depolarization and associated inward current and that this current is signaled by stimulation of 5-HT7 receptors. These results identify a physiological response elicited by the activation of 5-HT7 receptors in the thalamus.
| |
Materials and Methods |
|---|
|
|
|---|
Preparation of Brain Slices.
Male Sprague-Dawley rats
(p28-p42) were anesthetized with halothane and then decapitated. The
brain was removed and placed in ice-cold Ringer's solution
(composition in mM: 119 NaCl, 2.5 KCl, 1.3 MgSO4,
2.5 CaCl2, 1 NaH2PO4, 26.6 NaHCO3, and 11 glucose) bubbled to equilibrium
with 95% O2/5% CO2. The
cerebellum and the anterior forebrain were removed while the rest of
the brain was affixed to a stage with cyanoacrylate glue. A vibratome
was used to cut 400 µm thick brain slices containing the anterior thalamus. These slices were placed into a submerged chamber (Sakmann and Stuart, 1995
) containing constantly bubbled Ringer's solution and
left to recover for at least 1 h at room temperature. When recording, the slices were placed in a recording chamber (Nicoll and
Alger, 1981
) where they were held submerged between two nylon nets and
continuously perfused (1-2 ml/min) with normal Ringer's solution
bubbled with 95% O2/5%
CO2 at 30°C.
Electrophysiological Recordings.
Whole-cell recordings were
obtained from the anterodorsal (ADn) and anteroventral thalamic nuclei
using the "blind" tight-seal patch clamp recording technique
(Blanton et al., 1989
). The thalamic nuclei were identified using
visual landmarks, specifically the stria medullaris and the 4th
ventricle. A Flaming/Brown horizontal puller was used to make recording
pipettes from borosilicate glass, o.d. 1.2 mm (Sutter Instrument Co.,
Novato, CA). The pipettes were filled with either a potassium gluconate
solution (composition in mM: 115 potassium gluconate, 5 NaCl, 10 HEPES,
10 EGTA, 2 MgCl2, 1 CaCl2,
5 ATP, 0.5 GTP) or a cesium gluconate solution (composition in mM: 100 CsOH, 100 D-gluconic acid, 5 NaCl, 10 HEPES, 10 BAPTA, 1 MgCl2, 4 CaCl2, 5 ATP, and
0.5 GTP. The pH of these solutions was adjusted to 7.3 or 7.4 with KOH
or CsOH, respectively.
and was compensated by greater
than 70%.
Drugs were applied by dissolving the drugs at known concentrations in
the Ringer's solution perfusing into the bath. Where indicated, slices
were incubated with antagonists in the recovery chamber for greater
than an hour to ensure equilibrium of the drug at the receptor site.
Most drugs were obtained from Sigma (St. Louis, MO). Mesulergine and
methylsergide maleate were gifts from the Sandoz Research Institute
(East Hanover, NJ), ritanserin was a gift from Janssen Pharmaceutica
(Beerse, Belgium), and SB-269770 was a gift from SmithKline Beecham
(Philadelphia, PA).
Data Analysis.
Data were analyzed using Origin (Microcal
Software, Northampton, MA). The equation used to describe the
dose-response relationship was y = A1 + (A2
A1)/1 + e(x
x0)/dx, where
dx is the Hill slope, A1
and A2 are the minimum and maximum inward current, respectively, and x is the effective
concentration (EC50). Except where indicated,
data are presented as means ± S.E.M. The
pA2 value for mesulergine was estimated using the
following equation.
|
Reverse Transcriptase (RT)-Polymerase Chain Reaction (PCR).
The brain was removed as described previously and then manually
dissected to obtain the anterior thalamic nuclei for RNA isolation. RNASTAT 60 (Tel-Test, Friendswood, TX) was used to extract RNA from the
tissue according to the manufacturer's instructions. For single-cell
RT-PCR, whole-cell patch clamp was obtained by the blind tight-seal
technique and the cell's contents were removed by suction. The
electrode tip was then broken in a tube and the contents of the
electrode expelled. The tube was placed on dry ice until the RT
reaction was started. The cDNA was synthesized with 20 units of avian
myeloblastosis virus reverse transcriptase, 10 mM Tris, 50 mM KCl
(Roche Molecular Biochemicals, Indianapolis, IN and Promega, Madison,
WI), 4 µg of random hexanucleotide primers, 1 mM dNTPs, 50 units of
RNase inhibitor, and sterile water to make approximately 20 to 32 µl
of reaction mix. The reaction was left at 25°C for 10 min, placed at
42°C for 60 min, and then placed at 99°C for 5 min. The cDNA from
the 5-HT7 receptor was amplified using the
following primer pairs: 5'-GAATATCAACCGGAAGCTCTC (sense primer A);
5'-CTGGATCATGTATCATGACCC (anti-sense primer A') (Heidmann et al.,
1997
); and 5'-GTGGACTTGTGGAAAGCACC (anti-sense primer C'). These two
primer pairs should yield products of 132 bp for A to A' and 451 bp for
A to C'. The PCR reaction was performed in a Perkin-Elmer GeneAmp PCR
System 2400 (30-40 cycles of 95°C for 1 min, 60°C for 40 s,
and 72°C for 1 min). The amplification of both primer pairs was done
in 10 mM Tris/HCl, 50 mM KCl, 1.5 to 2.5 mM MgCl2, 200 µM
dNTP mix, 40 nmol of each primer at pH 8.3 with 5 units of
Taq DNA polymerase (Roche Molecular Biochemicals/Fisher Biotech, Pittsburgh. PA). Restriction analysis was done using AvaI and SphI (New England BioLabs, Beverly, MA)
according to the manufacturer's instructions.
| |
Results |
|---|
|
|
|---|
Effect of Serotonin in the Anterior Thalamus.
To locate a
serotonin response mediated by 5-HT7 receptors,
we focused on the anterior thalamus, a region where these receptors are
abundantly expressed (Gustafson et al., 1995
; To et al., 1995
). Bath
application of 5-HT (1-100 µM) elicited a membrane depolarization (Fig. 1) or inward current (Fig.
2) in the vast majority of neurons of the
ADn (121 of 123 cells tested). In contrast, comparable administration
of serotonin to cells of the anterior ventral thalamic nucleus resulted
in less consistent results; cells exhibited either no effect, a small
hyperpolarization, or a small depolarization (n = 10 cells tested). Accordingly, all experiments outlined in this paper were
conducted on cells of the ADn.
|
|
60 mV
(n = 50 cells). No obvious desensitization was observed
for this depolarization over repeated serotonin applications. Serotonin
still elicited a depolarization and inward current when recordings were
obtained using a cesium-based intracellular solution. Since the
cesium-based intracellular solutions affords better voltage clamping
conditions, all experiments aimed at identifying the receptor mediating
this current were done in this solution.
The ability of serotonin to induce a depolarization and inward current
in the ADn was concentration-dependent in the range of 300 nM to 100 µM. Figures 1 and 2 illustrate representative voltage and current
traces from cells recorded in either current clamp or voltage clamp
where increasing concentrations of serotonin induced increasing
amplitudes of depolarization and inward current, respectively. The
threshold for the 5-HT induction of the inward current was in the high
nanomolar range, and the EC50 was 1.7 ± 0.2 µM (n = 5 cells).
Single-Cell RT-PCR Analysis.
Previous in situ studies have
located 5-HT7 receptor mRNA in the ADn, but they
have not identified the cell types that expressed it (Lovenberg et al.,
1993
; Gustafson et al., 1995
; To et al., 1995
). These studies have
generally assumed that neurons are the source of the
5-HT7 message, but this has not been directly
investigated. Furthermore, there is evidence that thalamic glia express
5-HT7 receptor mRNA (Hirst et al., 1997
). If
5-HT7 receptors play a role in mediating the
depolarization we observed in the ADn, then 5-HT7
receptor mRNA must be expressed in the neurons of this nucleus. Therefore, we first tested this possibility by using single-cell RT-PCR
techniques. In four separate trials, we recorded from single cells in
the ADn and extracted the contents of these cells by suction, obtaining
the mRNA. We next performed RT-PCR to amplify 5-HT7 mRNA using primers chosen to amplify across
an intron to eliminate contamination by genomic DNA (Fig.
3A). Figure 3, B and C, depicts results
from one of nine cells in which this experiment was successful.
Administration of serotonin to this cell resulted in the characteristic
inward current described previously (Fig. 3B). Subsequent amplification
of this cell's contents using primers A and A' resulted in a band of
approximately 135-bp long, consistent with the prediction for
amplification of 5-HT7 receptor mRNA. In two
additional cells, we obtained similar results when using primers A + C
and A + A' in nested PCR reactions.
|
Identification of the 5-HT Receptor That Signals the Membrane
Depolarization in the ADn.
Although our single-cell RT-PCR
experiments indicated that the 5-HT7 mRNA is
produced in the cells from which we record, this did not prove the
receptor mediating the membrane depolarization was of the
5-HT7 subtype. In fact, previous in situ
hybridization studies have detected expression of mRNA for several
distinct serotonin receptor subtypes, including the
5-HT1A, 5-HT2A, and 5-HT2C receptors, over the ADn (Gustafson et al.,
1995
; To et al., 1995
; Wright et al., 1995
). Therefore, to identify
whether the 5-HT7 receptor subtype was indeed the
receptor responsible for the depolarization, we took advantage of the
distinct pharmacological profile of 5-HT7
receptors. This analysis was possible because the 5-HT-induced inward
current was reproducible, concentration-dependent, and
non-desensitizing.
DOI, and the estimated
5-CT/5-HT potency is consistent with the involvement of a
5-HT7 receptor in this response.
|
|
20%, n = 3 cells tested, data not
shown). In contrast to the effects of mesulergine and ritanserin, bath
administration of the 5-HT1 selective antagonist cyanopindolol (10 µM) failed to reduce the inward current elicited by
3 µM serotonin (Fig. 6A, n = 5 cells). This lack of
effect did not simply reflect failure of the antagonist to reach the receptors in the slice, because parallel applications of cyanopindolol to hippocampal slices blocked the 5-HT1A
receptor-mediated outward current (n = 2 cells tested,
data not shown).
|
|
|
| |
Discussion |
|---|
|
|
|---|
In this study, we have examined the possible involvement of 5-HT7 receptors in mediating the electrophysiological effects of serotonin in the anterior thalamus. We report that neurons of the ADn express 5-HT7 receptor mRNA as determined by single-cell RT-PCR and respond to serotonin administration with a depolarization or inward current. Based on a pharmacological analysis using selective agonists and antagonists, we conclude that this depolarization/inward current is signaled by activation of receptors of the 5-HT7 subtype.
Single-Cell RT-PCR Analysis.
Administration of serotonin
elicited a membrane depolarization or inward current in the vast
majority of ADn neurons examined in this study. As a first step to
examine the involvement of 5-HT7 receptors in
this response, we tested for the expression of
5-HT7 mRNA in these neurons. This was an
important first step because previous studies have reported the
expression of 5-HT7 receptor-mediated responses
in glial cells of the thalamus (Hirst et al., 1997
). This raised the
possibility that the 5-HT7 receptor expression detected by in situ hybridization and receptor autoradiography (Gustafson et al., 1995
; To et al., 1995
) in this brain region may be
non-neuronal. We used primers selective for the
5-HT7 receptor to amplify cDNA obtained from RT
reactions of mRNA from single cells of the ADn from which we recorded.
We found that neurons that respond to bath application of 5-HT also
express mRNA for the 5-HT7 receptor. This
observation was consistent with the possibility that this receptor may
mediate the 5-HT-induced response. However, by in situ hybridization,
several other serotonergic receptors appear to be expressed in the ADn
as well, including those of the 5-HT1A, the
5-HT2A, and 5-HT2C subtypes
(Wright et al., 1995
). This heterogeneity in serotonin receptor subtype
expression led us to conduct a pharmacological analysis of the receptor
mediating the 5-HT-induced depolarization and inward current in the
ADn.
Pharmacological Analysis. To identify the receptor subtype involved in signaling the serotonin inward current in this area, we first tested a variety of agonists. The 5-HT-induced depolarization/inward current was concentration-dependent and mimicked by 5-CT, which was approximately 10 to 20 times more potent than 5-HT. 8-OHDPAT functioned as a low intrinsic activity partial agonist, whereas DOI was without a detectable effect on these cells. We complemented these results by examining receptor subtype-selective antagonists. We found that mesulergine, methysergide, LSD, and SB-269770 blocked the 5-HT-induced inward current whereas cyanopindolol did not. Additionally, low micromolar concentrations of ritanserin, but not ketanserin, inhibited the response. Finally, we compared the affinities of mesulergine and cyanopindolol at the receptor mediating the inward current. Mesulergine competitively antagonized the response of serotonin with an apparent affinity (pA2) of 31 nM, whereas cyanopindolol was found to have no detectable affinity for the receptor involved.
The results of this pharmacological analysis allow us to identify the receptor signaling the serotonin-induced depolarization in the ADn. This receptor displays a rank order of agonist potency such that 5-CT > 5-HT > 8-OHDPAT, is relatively insensitive to ketanserin, and is insensitive to cyanopindolol (Lovenberg et al., 19935-HT-Induced Depolarizations.
Previous studies have shown that
among G-protein coupled 5-HT receptors, both
5-HT2 and 5-HT4 receptors
can mediate slow membrane depolarizations in central neurons (North and
Uchimura, 1989
; Andrade and Chaput, 1991
). The present results indicate
that 5-HT7 receptors now join these receptors in
being capable of mediating membrane depolarizations in the central
nervous system. Interestingly, it has been known for many years that an
additional "orphan" serotonin receptor also mediates membrane
depolarizations through a mechanism involving cAMP and up-regulation of
the cation-nonselective current Ih. In a previous
study in dorsal root ganglion neurons, it was suggested that this
"orphan" receptor may belong 5-HT7 subtype, but other receptor subtypes could not be excluded (Cardenas et al.,
1999
). In the accompanying paper, we rigorously test this hypothesis.
We find that the 5-HT7 receptor-mediated
depolarization we have identified in the ADn is indeed mediated by
Ih. These results identify a physiological
function for 5-HT7 receptors in the brain.
| |
Acknowledgments |
|---|
We thank Drs. M. J. Bannon, G. Kapatos, and the members of their laboratories for help with the single-cell PCR. We also thank Drs. A. Wa and S. Haj-Dahmane for helpful discussions.
| |
Footnotes |
|---|
Accepted for publication December 20, 2000.
Received for publication September 14, 2000.
This work was supported by Grant MH43985 from the National Institute of Mental Health. This study was also supported in part by a research grant (Joe Young, Sr.) from the State of Michigan.
Send reprint requests to: Dr. Rodrigo Andrade, Department of Psychiatry and Behavioral Neurosciences, Wayne State University School of Medicine, 2309 Scott Hall, Detroit, MI 48201. E-mail: randrade{at}med.wayne.edu
| |
Abbreviations |
|---|
5-HT, 5-hydroxytryptamine; 5-CT, 5-carboxamidotryptamine; 5-MeOT, 5-methoxytryptamine; 8-OHDPAT, 8-hydroxydipropylaminotetralin; DOI, 2,5-dimethoxy-4-iodoamphetamine; ADn, anterodorsal nucleus of the thalamus; BAPTA, 1,2-bis(2-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid; RT-PCR, reverse transcriptase-polymerase chain reaction; LSD, lysergic acid diethylamide; bp, base pair; EC50, effective concentration of 50%.
| |
References |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
C. Varela and S. M. Sherman Differences in Response to Serotonergic Activation between First and Higher Order Thalamic Nuclei Cereb Cortex, November 21, 2008; (2008) bhn208v1. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Xiang, L. Wang, and S. T. Kitai Modulation of Spontaneous Firing in Rat Subthalamic Neurons by 5-HT Receptor Subtypes J Neurophysiol, March 1, 2005; 93(3): 1145 - 1157. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. P. Bengtson, D. J. Lee, and P. B. Osborne Opposing Electrophysiological Actions of 5-HT on Noncholinergic and Cholinergic Neurons in the Rat Ventral Pallidum In Vitro J Neurophysiol, July 1, 2004; 92(1): 433 - 443. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-C. Beique, B. Campbell, P. Perring, M. W. Hamblin, P. Walker, L. Mladenovic, and R. Andrade Serotonergic Regulation of Membrane Potential in Developing Rat Prefrontal Cortex: Coordinated Expression of 5-Hydroxytryptamine (5-HT)1A, 5-HT2A, and 5-HT7 Receptors J. Neurosci., May 19, 2004; 24(20): 4807 - 4817. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-C. Beique, E. M. Chapin-Penick, L. Mladenovic, and R. Andrade Serotonergic facilitation of synaptic activity in the developing rat prefrontal cortex J. Physiol., May 1, 2004; 556(3): 739 - 754. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z.-w. Zhang Serotonin Induces Tonic Firing in Layer V Pyramidal Neurons of Rat Prefrontal Cortex during Postnatal Development J. Neurosci., April 15, 2003; 23(8): 3373 - 3384. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. E. Monckton and D. A. McCormick Neuromodulatory Role of Serotonin in the Ferret Thalamus J Neurophysiol, April 1, 2002; 87(4): 2124 - 2136. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. M. Chapin and R. Andrade A 5-HT7 Receptor-Mediated Depolarization in the Anterodorsal Thalamus. II. Involvement of the Hyperpolarization-Activated Current Ih J. Pharmacol. Exp. Ther., April 1, 2001; 297(1): 403 - 409. [Abstract] [Full Text] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||